Encompass Health Corp 8-K

What Happened

• Encompass Health Corporation filed an 8-K on February 5, 2026 to announce its financial results for the three months and year ended December 31, 2025. The company attached a press release (Exhibit 99.1) and supplemental information for the fourth-quarter 2025 earnings call (Exhibit 99.2). The filing explains the company’s use of “same-store” comparisons to describe changes in performance metrics, and notes that those comparisons include results from market consolidation transactions and capacity expansions.

Key Details

• Filing date: February 5, 2026; reporting periods: three months and year ended December 31, 2025.
• Press release: Exhibit 99.1 (dated Feb 5, 2026); supplemental earnings-call materials: Exhibit 99.2; cover page iXBRL: Exhibit 104.
• Same-store methodology: comparisons are based on hospitals open throughout both current and prior periods and include market consolidations and capacity expansions (e.g., satellites/remote hospitals).
• Regulation FD disclosure: the attached information is furnished under Item 7.01 and is not “filed” for certain legal purposes; the report is signed by Douglas E. Coltharp, EVP & CFO.

Why It Matters

• This 8-K provides the company’s official Q4 and full-year 2025 results and the materials investors should review to see revenue, earnings, and operational trends.
• The same-store explanation matters because it clarifies how Encompass Health adjusts like‑for‑like metrics when acquisitions or capacity additions affect comparability—important when evaluating growth and margin trends.
• Investors should read the attached press release and supplemental slides for the specific financial figures, trends, and any management commentary tied to the earnings call.